SkyePharma PLC - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for SkyePharma PLC. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

SkyePharma PLC. The Group's principal activity is researching and developing, manufacturing and selling prescription pharmaceutical products. It uses multiple drug delivery technologies to create a product pipeline for out-licensing to marketing partners. Its product brands include Flutiform, Foradil Certihaler, Paxil CR, Xatral OD, Solaraze, Triglide, Lodotra, Requip Once-a-day, Sular and ZYFLO CR. The Group's product pipelines are oral, inhalation, injectable, topical and solubilisation.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report